Literature DB >> 23811340

Ovarian cancer ascites-derived vitronectin and fibronectin: combined purification, molecular features and effects on cell response.

Ludovic Carduner1, Rémy Agniel, Sabrina Kellouche, Cédric R Picot, Cécile Blanc-Fournier, Johanne Leroy-Dudal, Franck Carreiras.   

Abstract

BACKGROUND: Intra-abdominal ascites is a complication of ovarian cancers and constitutes a permissive microenvironment for metastasis. Since fibronectin and vitronectin are key actors in ovarian cancer progression, we investigated their occurrence and molecular characteristics in various ascites fluids and the influence of these ascites-derived proteins on cell behavior.
METHODS: Fibronectin and vitronectin were investigated by immunoblotting within various ascites fluids. A combined affinity-based protocol was developed to purify both proteins from the same sample. Each purified protein was characterized with regard to its molecular features (molecular mass of isoforms, tryptophan intramolecular environment, hydrodynamic radii), and its influence on cell adhesion.
RESULTS: Fibronectin and vitronectin were found in all tested ascites. Several milligrams of purified proteins were obtained from ascites of varying initial volumes. Molecular mass isoforms and conformational lability of proteins differed according to the ascites of origin. When incorporated into the cancer cell environment, ascites-derived fibronectin and vitronectin supported cell adhesion and migration with various degrees of efficiency, and induced the recruitment of integrins into focal contacts.
CONCLUSIONS: To our knowledge, this is the first combined purification of two extracellular matrix proteins from a single pathological sample containing a great variety of bioactive molecules. This study highlights that ascites-derived fibronectin and vitronectin exhibit different properties depending on the ascites. GENERAL SIGNIFICANCE: Investigating the relationships between the molecular properties of ascites components and ovarian cancer cell phenotype according to the ascites may be critical for a better understanding of the recurrence of this lethal disease and for further biomarker identification.
© 2013.

Entities:  

Keywords:  Affinity chromatography; Ascites; ECM; Fibronectin; Fn; Microenvironment; Vitronectin; Vn; extracellular matrix; fibronectin; kDa; kilodaltons; vitronectin

Mesh:

Substances:

Year:  2013        PMID: 23811340     DOI: 10.1016/j.bbagen.2013.06.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Vitronectin in the ascites of human ovarian carcinoma acts as a potent chemoattractant for ovarian carcinoma: Implication for metastasis by cancer stem cells.

Authors:  Gabriela Schneider; Malwina Suszynska; Sham Kakar; Mariusz Z Ratajczak
Journal:  J Cancer Stem Cell Res       Date:  2016-11-30

2.  FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.

Authors:  Isabelle Tancioni; Sean Uryu; Florian J Sulzmaier; Nina R Shah; Christine Lawson; Nichol L G Miller; Christine Jean; Xiao Lei Chen; Kristy K Ward; David D Schlaepfer
Journal:  Mol Cancer Ther       Date:  2014-06-04       Impact factor: 6.261

3.  Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins.

Authors:  L Carduner; J Leroy-Dudal; C R Picot; O Gallet; F Carreiras; S Kellouche
Journal:  Clin Exp Metastasis       Date:  2014-06-20       Impact factor: 5.150

4.  Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities.

Authors:  Gabriela Schneider; Ewa Bryndza; Agata Poniewierska-Baran; Karol Serwin; Malwina Suszynska; Zachariah P Sellers; Michael L Merchant; Alagammai Kaliappan; Janina Ratajczak; Magda Kucia; Nichola C Garbett; Mariusz Z Ratajczak
Journal:  Oncotarget       Date:  2016-10-25

5.  Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK.

Authors:  Xin Liang; Jianxin Ju
Journal:  Oncol Rep       Date:  2021-03-31       Impact factor: 3.906

6.  Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry.

Authors:  Pierre Nizet; Valérie Untereiner; Ganesh D Sockalingum; Isabelle Proult; Christine Terryn; Albin Jeanne; Lise Nannan; Camille Boulagnon-Rombi; Christèle Sellier; Romain Rivet; Laurent Ramont; Stéphane Brézillon
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

Review 7.  Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.

Authors:  Kaname Uno; Shohei Iyoshi; Masato Yoshihara; Kazuhisa Kitami; Kazumasa Mogi; Hiroki Fujimoto; Mai Sugiyama; Yoshihiro Koya; Yoshihiko Yamakita; Akihiro Nawa; Tomohiro Kanayama; Hiroyuki Tomita; Atsushi Enomoto; Hiroaki Kajiyama
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

8.  Deciphering the ovarian cancer ascites fluid peptidome.

Authors:  Anand Bery; Felix Leung; Christopher R Smith; Eleftherios P Diamandis; Vathany Kulasingam
Journal:  Clin Proteomics       Date:  2014-04-02       Impact factor: 3.988

9.  Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells.

Authors:  Sonia Capellero; Jessica Erriquez; Chiara Battistini; Roberta Porporato; Giulia Scotto; Fulvio Borella; Maria F Di Renzo; Giorgio Valabrega; Martina Olivero
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.